| Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus M Petri, AM Orbai, GS Alarcón, C Gordon, JT Merrill, PR Fortin, IN Bruce, ... Arthritis & Rheumatism 64 (8), 2677-2686, 2012 | 6146 | 2012 |
| Derivation of the SLEDAI. A disease activity index for lupus patients C Bombardier, DD Gladman, MB Urowitz, D Caron, CH Chang, A Austin, ... Arthritis & Rheumatism: Official Journal of the American College of …, 1992 | 5846 | 1992 |
| Classification criteria for psoriatic arthritis: development of new criteria from a large international study W Taylor, D Gladman, P Helliwell, A Marchesoni, P Mease, H Mielants Arthritis & Rheumatism: Official Journal of the American College of …, 2006 | 4494 | 2006 |
| Systemic lupus erythematosus disease activity index 2000. DD Gladman, D Ibaņez, MB Urowitz The Journal of rheumatology 29 (2), 288-291, 2002 | 4064 | 2002 |
| 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus M Aringer, K Costenbader, D Daikh, R Brinks, M Mosca, ... Arthritis & rheumatology 71 (9), 1400-1412, 2019 | 3546 | 2019 |
| The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus D Gladman, E Ginzler, C Goldsmith, P Fortin, M Liang, ... Arthritis & Rheumatism: Official Journal of the American College of …, 1996 | 2836 | 1996 |
| Psoriatic arthritis: epidemiology, clinical features, course, and outcome DD Gladman, C Antoni, P Mease, DO Clegg, P Nash Annals of the rheumatic diseases 64, ii14-ii17, 2005 | 2106 | 2005 |
| Methods for assessing responsiveness: a critical review and recommendations JA Husted, RJ Cook, VT Farewell, DD Gladman Journal of clinical epidemiology 53 (5), 459-468, 2000 | 1755 | 2000 |
| Genome-wide scan reveals association of psoriasis with IL-23 and NF-κB pathways RP Nair, KC Duffin, C Helms, J Ding, PE Stuart, D Goldgar, ... Nature genetics 41 (2), 199-204, 2009 | 1687 | 2009 |
| Psoriatic arthritis CT Ritchlin, RA Colbert, DD Gladman New England Journal of Medicine 376 (10), 957-970, 2017 | 1576 | 2017 |
| Mortality in systemic lupus erythematosus S Bernatsky, JF Boivin, L Joseph, S Manzi, E Ginzler, DD Gladman, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2006 | 1411 | 2006 |
| Psoriatic arthritis (PSA)-an analysis of 220 patients DD Gladman, R Shuckett, ML Russell, JC Thorne, RK Schachter QJM: An International Journal of Medicine 62 (2), 127-141, 1987 | 1383* | 1987 |
| Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis: results of a double‐blind, randomized, placebo‐controlled trial PJ Mease, DD Gladman, CT Ritchlin, EM Ruderman, SD Steinfeld, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2005 | 1212 | 2005 |
| Group for research and assessment of psoriasis and psoriatic arthritis 2015 treatment recommendations for psoriatic arthritis LC Coates, A Kavanaugh, PJ Mease, ER Soriano, ... Arthritis & rheumatology 68 (5), 1060-1071, 2016 | 1125 | 2016 |
| Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity LC Tsoi, SL Spain, J Knight, E Ellinghaus, PE Stuart, F Capon, J Ding, ... Nature genetics 44 (12), 1341-1348, 2012 | 1122 | 2012 |
| Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility Australo-Anglo-American Spondyloarthritis Consortium (TASC), ... Nature genetics 43 (8), 761-767, 2011 | 1011 | 2011 |
| Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: results from the infliximab multinational psoriatic arthritis … CE Antoni, A Kavanaugh, B Kirkham, Z Tutuncu, GR Burmester, ... Arthritis & Rheumatism 52 (4), 1227-1236, 2005 | 845 | 2005 |
| 2018 American College of Rheumatology/National Psoriasis Foundation guideline for the treatment of psoriatic arthritis JA Singh, G Guyatt, A Ogdie, DD Gladman, C Deal, A Deodhar, ... Journal of Psoriasis and Psoriatic Arthritis 4 (1), 31-58, 2019 | 828 | 2019 |
| Golimumab, a new human tumor necrosis factor α antibody, administered every four weeks as a subcutaneous injection in psoriatic arthritis: twenty‐four–week efficacy and safety … A Kavanaugh, I McInnes, P Mease, GG Krueger, D Gladman, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2009 | 823 | 2009 |
| The reliability of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index in patients with systemic lupus erythematosus DD Gladman, MB Urowitz, CH Goldsmith, P Fortin, E Ginzler, C Gordon, ... Arthritis & Rheumatism: Official Journal of the American College of …, 1997 | 802 | 1997 |
